Prior Intimation of Board Meeting

DR. LAL PATH LABS LTD.

General Information

NSE Symbol*		LALPATHLAB
Whether Company is SME*		No
ISIN*		INE600L01024
Type of Meeting		Board Meeting
Details of Committee Meeting or Other Type of Meeting
Type of Intimation*		New
Reason for Re-schedule (postpone or prepone) / Cancellation
Proposed Meeting Date		30-04-2026
Original Meeting Date
Whether trading window is closed*		Yes
Trading Window Closure- Start date		01-04-2026
Details of Trading Window Closure End date		02-05-2026
Date of Report		23-04-2026

Agenda*		Dividend
Whether results are audited or unaudited
Nature of report standalone or consolidated
Period end Type
Period up to (Month)
Period up to (Year)
Mode of raising Funds
Type of Dividend		Final
Remarks (website dissemination)		This is in continuation of our earlier intimation dated March 27, 2026, with respect to Intimation of Board Meeting scheduled to be held on Thursday, April 30, 2026 to inter-alia consider and approve the Audited (Standalone & Consolidated) Financial Results of the Company for the Quarter and Financial Year ended on March 31, 2026. We would like to further inform you that the Board of Directors at the same meeting scheduled for April 30, 2026, shall also consider & recommend Final Dividend, if any, on the Equity Shares of the Company for the Financial Year 2025-26.